Latest Strategic Investments News

Page 74 of 79
Carbonxt has marked a pivotal quarter with the mechanical completion of its Kentucky activated carbon plant, a 14% rise in powdered activated carbon sales, and a successful $1.03 million capital raise, setting the stage for stronger revenue growth in 2025.
Victor Sage
Victor Sage
31 Jan 2025
Altamin Limited has completed its acquisition of Appian's stake in Vedra Metals, gaining 100% ownership of the Gorno Project, while advancing environmental assessments and development plans for its Lazio geothermal lithium project. A recent $3.2 million capital raise underpins its dual strategy to unlock value and progress key assets.
Maxwell Dee
Maxwell Dee
31 Jan 2025
HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.
Claire Turing
Claire Turing
31 Jan 2025
Duxton Farms Limited reported a robust Q2 FY2025, driven by favourable weather conditions and strategic investments, including a share buyback and increased stakes in agricultural ventures. The company recorded a $2.24 million operating cash flow surplus amid mixed crop yields and ongoing diversification.
Ada Torres
Ada Torres
31 Jan 2025
Greenwing Resources reports significant progress in its lithium and graphite projects, notably expanding the lithium brine footprint at its San Jorge Project in Argentina and advancing exploration in Madagascar amid regulatory shifts.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.
Ada Torres
Ada Torres
31 Jan 2025
Fatfish Group reported a 20% increase in cash receipts to A$0.76 million for Q4 2024, driven by advances in its AI gaming subsidiary, but rising operating expenses led to a net cash outflow of A$0.37 million.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Voltaic Strategic Resources reports significant gold and poly-metallic mineralisation at its Kooline and Meekatharra projects, alongside a strategic board restructure and a robust cash position of $5.4 million.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.
Victor Sage
Victor Sage
31 Jan 2025
Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.
Ada Torres
Ada Torres
31 Jan 2025